ArticleJournal of comparative effectiveness research2024
First in class, best in class or a wild card: who will dominate the anti-obesity medication market?
Emma Collins et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it